ulcerative colitis
Conditions
Interventions
Control Group:Sham stimulation + Mesalazine
SNS Group:Acupuncture + sacral nerve stimulation + Mesalazine
Sponsors
Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years old, male or female; 2. Meet the western diagnostic criteria for ulcerative colitis, and specifically refer to the consensus opinions on the diagnosis and treatment of inflammatory bowel disease (Beijing, 2018); 3. Mild to moderate active UC confirmed to be recurrent (Mayo Risk score 3-10); 4. Patients can communicate well with researchers; 5. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Subjects in remission or graded as severe; 2. Allergic to Mesalqin or relevant ingredients; 3. Complicated with short bowel syndrome, ostomy, symptomatic intestinal stenosis, intestinal perforation, abdominal abscess, tumor, toxic megacolon, etc.; 4. Subjects with serious heart, liver, lung, kidney, blood or serious diseases affecting their survival; 5. Pregnant and lactating women; 6. Unable to cooperate in completing the research process; 7. Participated in other clinical research within the past 3 months; 8. SUbjects not suitable to participate in this study judged by the doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mayo Risk Score;Mucosal healing rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Physicochemical indices;Inflammatory Bowel Disease Questionnaire;Visual Analogue Scale,VAS; | — |
Countries
China
Contacts
Public ContactDong Yan
Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed